WEREWOLF THERAPEUTICS, INC. Investment Income, Net
WEREWOLF THERAPEUTICS, INC. (HOWL) reported Investment Income, Net of $971.00 thousand for the 3-month period ending 2023-09-30, per its 10-Q filed 2023-11-14.
Discontinued › Income Statement › Other Income
us-gaap:InvestmentIncomeNet · last filed 2023-11-14
- WEREWOLF THERAPEUTICS, INC. investment income, net for the quarter ending 2023-09-30 was $971.00K, a 63.74% increase year-over-year.
- WEREWOLF THERAPEUTICS, INC. investment income, net for the quarter ending 2023-06-30 was $994.00K, a 924.74% increase year-over-year.
- WEREWOLF THERAPEUTICS, INC. investment income, net for the quarter ending 2023-03-31 was $1.35M, a 3353.85% increase year-over-year.
- WEREWOLF THERAPEUTICS, INC. investment income, net for the quarter ending 2022-12-31 was $1.18M.
- WEREWOLF THERAPEUTICS, INC. investment income, net for fiscal 2022 was $1.91M, a 1734.62% increase from fiscal 2021.
- WEREWOLF THERAPEUTICS, INC. investment income, net for fiscal 2021 was $104.00K, a 65.08% increase from fiscal 2020.
- WEREWOLF THERAPEUTICS, INC. investment income, net for fiscal 2020 was $63.00K.
| Period end | Investment Income, Net 3 month | Investment Income, Net 3 month as first filed | Investment Income, Net 6 month | Investment Income, Net 9 month | Investment Income, Net 9 month as first filed | Investment Income, Net 12 month |
|---|---|---|---|---|---|---|
| 2023-09-30 | $971.00K 10-Q · filed 2023-11-14 | $1.97M derived: sum of 2 quarters · filed 2023-11-14 | $3.31M 10-Q · filed 2023-11-14 | $4.49M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2023-06-30 | $994.00K 10-Q · filed 2023-08-10 | $2.34M 10-Q · filed 2023-08-10 | $3.52M derived: sum of 3 quarters · filed 2023-08-10 | $4.11M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2023-03-31 | $1.35M 10-Q · filed 2023-05-11 | $2.53M derived: sum of 2 quarters · filed 2023-05-11 | $3.12M derived: sum of 3 quarters · filed 2023-11-14 | $3.22M derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-12-31 | $1.18M derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $1.77M derived: sum of 2 quarters · filed 2023-11-14 | $1.87M derived: sum of 3 quarters · filed 2023-11-14 | $1.91M 10-K · filed 2023-03-23 | ||
| 2022-09-30 | $593.00K 10-Q · filed 2023-11-14 | $690.00K derived: sum of 2 quarters · filed 2023-11-14 | $729.00K 10-Q · filed 2023-11-14 | $695.00K derived: sum of 4 quarters · filed 2023-11-14 | ||
| 2022-06-30 | $97.00K 10-Q · filed 2023-08-10 | $136.00K 10-Q · filed 2023-08-10 | $102.00K derived: sum of 3 quarters · filed 2023-08-10 | $156.00K derived: sum of 4 quarters · filed 2023-08-10 | ||
| 2022-03-31 | $39.00K 10-Q · filed 2023-05-11 | $23.00K 10-Q · filed 2022-05-10 | $5.00K derived: sum of 2 quarters · filed 2023-05-11 | $59.00K derived: sum of 3 quarters · filed 2023-05-11 | $110.00K derived: sum of 4 quarters · filed 2023-05-11 | |
| 2021-12-31 | -$34.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-23 | $20.00K derived: sum of 2 quarters · filed 2023-03-23 | $71.00K derived: sum of 3 quarters · filed 2023-03-23 | $104.00K 10-K · filed 2023-03-23 | ||
| 2021-09-30 | $54.00K 10-Q · filed 2022-11-10 | $37.00K 10-Q · filed 2021-11-10 | $105.00K derived: sum of 2 quarters · filed 2022-11-10 | $138.00K 10-Q · filed 2022-11-10 | $89.00K 10-Q · filed 2021-11-10 | $112.00K derived: sum of 4 quarters · filed 2022-11-10 |
| 2021-06-30 | $51.00K 10-Q · filed 2022-08-11 | $84.00K 10-Q · filed 2022-08-11 | $58.00K derived: sum of 3 quarters · filed 2022-08-11 | $43.00K derived: sum of 4 quarters · filed 2022-08-11 | ||
| 2021-03-31 | $17.00K 10-Q · filed 2022-05-10 | $33.00K 10-Q · filed 2021-06-10 | $7.00K derived: sum of 2 quarters · filed 2022-05-10 | -$8.00K derived: sum of 3 quarters · filed 2022-05-10 | $16.00K derived: sum of 4 quarters · filed 2022-05-10 | |
| 2020-12-31 | -$10.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-24 | -$25.00K derived: sum of 2 quarters · filed 2022-03-24 | -$1.00K derived: sum of 3 quarters · filed 2022-03-24 | $63.00K 10-K · filed 2022-03-24 | ||
| 2020-09-30 | -$15.00K 10-Q · filed 2021-11-10 | $9.00K derived: sum of 2 quarters · filed 2021-11-10 | $73.00K 10-Q · filed 2021-11-10 | |||
| 2020-06-30 | $24.00K 10-Q · filed 2021-08-12 | $91.00K 10-Q · filed 2021-08-12 | ||||
| 2020-03-31 | $67.00K 10-Q · filed 2021-06-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Grace Therapeutics, Inc. (GRCE) | $0.046B | -1.83 | |
| Dogwood Therapeutics, Inc. (DWTX) | United States | $0.049B | |
| Lite Strategy, Inc. (LITS) | United States | $0.049B | |
| Elicio Therapeutics, Inc. (ELTX) | United States | $0.049B | |
| PDS Biotechnology Corp (PDSB) | United States | $0.045B | |
| SCYNEXIS INC (SCYX) | United States | $0.045B | |
| VERU INC. (VERU) | United States | $0.043B | -3.93 |
| Xilio Therapeutics, Inc. (XLO) | United States | $0.052B | |
| Kairos Pharma, LTD. (KAPA) | United States | $0.041B | |
| Incannex Healthcare Inc. (IXHL) | $0.040B | -22.32 |